Abstract
The aggregation processes of amyloid proteins in vivo are associated with the pathogenesis of several incurable neurologic diseases and in vitro they preclude or shows limitations both in storage and therapeutic applications such as on the biopharmaceutical protein insulin. However, stabilizing this conformation has disadvantages, since insulin is active in the monomeric form and dissocia…